【摘要】 目的:为抗精神病药的合理使用提供参考。方法:对2002、2006年河北省精神卫生中心既往药物调查的数据库以及2012年11个地级市39家精神卫生机构药物调查的数据中提取的共5 014例精神分裂症患者的一般情况和抗精神病药治疗信息进行统计分析。结果:随年份增加,第一代抗精神病药的使用频率下降(P<0.05),第二代抗精神病药使用频率上升(P<0.01);2002、2006、2012年门诊与住院患者长效抗精神病药使用频率普遍较低,3年相比差异有统计学意义(P<0.01);而抗精神病药单一及联合治疗的门诊患者所占比例3年相比差异无统计学意义(P>0.05);随年份增加,抗精神病药单一治疗的住院患者比例下降,联合治疗的住院患者比例上升(χ2=18.682,P<0.01)。结论:2002-2012年间,第二代抗精神病药逐渐取代第一代抗精神病药,成为河北省治疗精神分裂症患者的主导药物,抗精神病药联合治疗的住院患者比例升高,此现象与国内外防治指南规定有偏差。更多还原

【Abstract】 OBJECTIVE:To provide reference for rational use of antipsychotic drugs in schizophrenia patients. METHODS:The general information and antipsychotic treatment information,which were extracted from the database of prior drug investigation in Mental Health Center of Hebei Province in 2002,2006 and investigation data in 2012 of 5014 schizophrenia patients,were analyzed. RESULTS:Over time,the frequency of the first generation antipsychotic drugs decreased(P<0.05),while that of the second generation antipsychotic drugs increased(P<0.01). The frequency of long-acting antipsychotic drugs were generally low among outpatients and inpatients in 2002,2006,2012,with statistical significance(P<0.01). There were no significant difference in the proportion of outpatients receiving antipsychotic drugs combination treatment and monotherapy(P>0.05). Over time,the proportion of inpatients receiving monotherapy decreased,while that of inpatients receiving combination treatment increased(χ2=18.682,P<0.01). CONCLUSIONS:The second generation antipsychotic drugs have gradually replaced the first generation antipsychotic drugs,and have became the leading drugs in the treatment of schizophrenia in Hebei province. The proportion of inpatients receiving combination treatment has increased,which is different from the domestic and foreign prevention and treatment guidelines.更多还原